CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct. 31, 2013--
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the fields of
cancer metabolism and inborn errors of metabolism, today announced that
the company will host a conference call and live audio webcast on
Thursday, November 7, 2013, at 8:30 a.m. EST to report its third quarter
2013 financial results and discuss recent business activities.
In order to participate in the conference call, please dial
1-877-377-7098 (domestic) or 1-631- 291-4547 (international) and refer
to conference ID 92532816. The live webcast can be accessed under
"Events & Presentations" in the Investors and Media section of the
company's website at www.agios.com.
The archived webcast will be available on the company's website
beginning approximately two hours after the event.
About Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals is focused on discovering and developing novel
drugs to treat cancer and inborn errors of metabolism, or IEMs, which
are a subset of orphan genetic metabolic diseases, through scientific
leadership in the field of cellular metabolism. In addition to an active
research and discovery pipeline across both therapeutic areas, Agios has
multiple first-in-class lead product candidates in cancer metabolism and
IEMs in clinical and/or preclinical development. All Agios programs
focus on genetically identified patient populations, leveraging our
knowledge of metabolism, biology and genomics. For more information,
please visit our website at www.agios.com.
Source: Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals:
Glenn Goddard
SVP Finance
investors@agios.com
or
Media
Contact:
Dan Budwick, 973-271-6085
dan@purecommunicationsinc.com
